Literature DB >> 846306

Lipid metabolism in plasma, liver, and adipose tissue of rats with experimental chronic nephrotic syndrome.

R J Morin, W D Davidson, S J Rorke, L S Guo.   

Abstract

Plasma, liver, and adipose tissue lipid composition and synthesis from [1-14C] acetate were studied three months following induction of nephrotic syndrome in rats by injection of antiglomerular basement membrane protein. Plasma triglyceride concentrations and specific radioactivities were elevated, and the triglycerides contained increased proportions of oleic acid. Plasma cholesterol and phospholipid concentrations were also increased, but free fatty acid levels were not. Liver triglyceride concentrations were decreased and incorporation of [1-14] acetate into liver triglycerides was also depressed below that of normal controls. Nephrotic rat liver triglycerides contained a higher proportion of oleic acid and lower arachidonic acid than did controls. Incorporation of [1-14C] acetate into adipose tissue lipids of the nephrotic rats was increased, and the proportion of palmitic acid was decreased. In the chronic nephrotic rat, the major source of the increased plasma triglycerudes may be fatty acids mobilized from adipose tissue stores.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 846306     DOI: 10.1007/BF02533296

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  17 in total

1.  The distribution of cholesterol and total lipids in the nephrotic rat.

Authors:  R H ROSENMAN; M FRIEDMAN; S O BYERS
Journal:  J Clin Invest       Date:  1955-05       Impact factor: 14.808

2.  Metabolic channeling in experimental nephrosis. II. Lipide metabolism.

Authors:  J B MARSH; D L DRABKIN
Journal:  J Biol Chem       Date:  1955-02       Impact factor: 5.157

3.  Hyperlipemia of antiserum nephrosis. I. Rate of synthesis of plasma cholesterol.

Authors:  H S SODHI; N KALANT
Journal:  Metabolism       Date:  1963-05       Impact factor: 8.694

4.  Metabolic channeling in experimental nephrosis. V. Lipide metabolism in the early stages of the disease.

Authors:  J B MARSH; D L DRABKIN
Journal:  J Biol Chem       Date:  1958-02       Impact factor: 5.157

5.  Tissue distribution of C-14 after the intravenous injection of labeled free fatty acids and chylomicrons in nephrotic rats.

Authors:  C L MALMENDIER
Journal:  J Clin Invest       Date:  1962-01       Impact factor: 14.808

6.  Continuous measurement of 14C-labeled substrate oxidation to 14CO2 by isolated tissues: an ionization chamber method.

Authors:  J C Thompson; W D Davidson; A D Schwabe
Journal:  Anal Biochem       Date:  1968-12       Impact factor: 3.365

7.  One-day renal function testing in normal rats and in cases of experimentally-induced analgesic nephropathy, nephrocalcinosis and nephrotic syndrome.

Authors:  K D Edwards; E A Curtis; L M Stoker
Journal:  Nephron       Date:  1971       Impact factor: 2.847

8.  Simplified manual micromethod for determination of serum triglycerides.

Authors:  F G Soloni
Journal:  Clin Chem       Date:  1971-06       Impact factor: 8.327

9.  Determinants of glomerular filtration in experimental glomerulonephritis in the rat.

Authors:  D A Maddox; C M Bennett; W M Deen; R J Glassock; D Knutson; T M Daugharty; B M Brenner
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

10.  Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome.

Authors:  I F McKenzie; P J Nestel
Journal:  J Clin Invest       Date:  1968-07       Impact factor: 14.808

View more
  2 in total

1.  Effects of low casein and fish oil on hyperlipidemia and proteinuria in nephritic rats.

Authors:  K Fujisawa; K Yagasaki; R Funabiki
Journal:  Lipids       Date:  1994-11       Impact factor: 1.880

2.  Lipoprotein lipid and protein synthesis in experimental nephrosis and plasmapheresis: II. Perfused rat liver.

Authors:  T Brenner; E Shafrir
Journal:  Lipids       Date:  1980-09       Impact factor: 1.880

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.